Malononitrile; 109-77-3] 및 이를 25% 이상 함유한 혼합물질 급성 흡입독성
2019-31 2-부틴-1,4-디올[2-Butyne-1,4-diol; 110-65-6] 및 이를 25% 이상 함유한 혼합물질 급성 흡입독성
2019-32 디-n-부틸아민 [Di-n-butylamine; 111-92-2] 및 이를 25% 이상 함유한 혼합물질
급성 흡입독성
and reduced caking compared
to the bulk material. Stability studies at ambient (25 °C/60% rH) and acceler-
ated (40 °C/75% rH) conditions showed that powders formed solid monoblocs
whereas granules kept
acetonitrile/water 75/25 (v/v),
flow rate: 1.3 mL/min,
250 x 4.6 mm columns
Pressure
≤40 bar (10 µm)
10 bar
Acetonitril/water 75/25 (v/v),
flow rate: 1.3 mL/min,
250 x 4.6 mm columns≤25 bar (20 µm)
Millex®-GS filter unit: 25 mm (0.98 in.)
Millex®-HA filter unit: 25 mm (0.98 in.)
29 mm (1.14 in.)
4 cm² (0.62 in²)
Temperature limit 45 °C (113 °F)
Pressure limit at 25 °C 5.2 bar (75 psi) inlet and differential
depletion method. Two
75-ml samples of human serum were processed using the ProteoPrep Blue Albumin
Depletion Kit equilibrated either with the supplied urea-based buffer (Lanes 2 and 5)
or with 25 mM Tris-HCl
Hi-Flow™ Plus 75, 90, 120, 135, 180 2 mil 25 cm x 30.5 cm sheets 10 sh/pk
(2 sheets of each speed)
HFSAMPLE02
Hi-Flow™ Plus 75, 90, 120, 135, 180 4 mil 25 cm x 30.5 cm
Hi-Flow™ Plus 75, 90, 120, 135, 180 2 mil 25 cm x 30.5 cm sheets 10 sh/pk
(2 sheets of each speed)
HFSAMPLE02
Hi-Flow™ Plus 75, 90, 120, 135, 180 4 mil 25 cm x 30.5 cm
Incubation solution 150 �l 150 �l 150 �l
Color reagent I 75 �l 75 �l 75 �l
Color reagent II 75 �l 75 �l 75 �l
mix, incubate for 5 min at +15 to +25°C and read
TMP
Arg
0
25
100
125
75
50
B
Figure 7.
Monomer content of A) infliximab and B) evolocumab formulations after a forced degradation study of 28 days at 40 °C/75%
.288 µm 0.413 µm 0.422 µm 0.478 µm
C
T
0 25 160 300 1600 16000
mIU hCG/mL
Figure 2a. Signal intensity for hCG detection on Hi-Flow™ Plus 75
using Estapor® microspheres of different diameters